Best management of patients with an acute sore throat - a critical analysis of current evidence and a consensus of experts from different countries and traditions

Infect Dis (Lond). 2023 Jun;55(6):384-395. doi: 10.1080/23744235.2023.2191714. Epub 2023 Mar 27.

Abstract

Background: There is a very large body of publications discussing the management of patients with an acute sore throat. Advocates for a restrictive antibiotic policy and advocates for a more liberal use of antibiotics emphasise different and valid arguments and to date have not been able to unite in a consensus. Contradicting guidelines based on the same body of knowledge is not logical, may cause confusion and cause unwanted variation in clinical management.

Methods: In multiple video meetings and email correspondence from March to November 2022 and finally in a workshop at the annual meeting for the North American Primary Care Group in November 2022, experts from different countries representing different traditions agreed on how the current evidence should be interpreted.

Results: This critical analysis identifies that the problem can be resolved by introducing a new triage scheme considering both the acute risk for suppurative complications and sepsis as well as the long-term risk of developing rheumatic fever.

Conclusions: The new triage scheme may solve the long-standing problem of advocating for a restrictive use of antibiotics while also satisfying concerns that critically ill patients might be missed with severe consequences. We acknowledge that the perspective of this problem is vastly different between high- and low-income countries. Furthermore, we discuss the new trend which allows nurses and pharmacists to independently manage these patients and the increased need for safety netting required for such management.

Keywords: Pharyngitis; antimicrobial stewardship; guidelines as topic; point-of-care testing; signs and symptoms; triage.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Consensus
  • Humans
  • Pharyngitis* / drug therapy

Substances

  • Anti-Bacterial Agents